Advertisement
Stat News

STAT+: Medicare chief says TrumpRx is meant to be narrow in scope

STAT+: Medicare chief says TrumpRx is meant to be narrow in scope

Today's biotech news includes the Medicare director offering a tempered view of TrumpRx and high-dose Wegovy getting an FDA nod.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement